General Description: This individual is responsible for the development, implementation, and execution of tactics related to myBeOne Support, program education, awareness and promotions to support the continued growth of BRUKINSA (zanubrutinib), BEQALZI (sonrotoclax), TEVIMBRA (tislelizumab) and upcoming new indications and new molecular entity launches. Actual compensation packages are determined by several factors that are unique to each candidate, including but not limited to job-related skills, depth of experience, certifications, relevant education or training, and specific work location.